VYNE Therapeutics (VYNE) EPS (Basic) (2017 - 2025)
VYNE Therapeutics (VYNE) posted EPS (Basic) of -$0.0 for Q2 2025, little changed on a QoQ basis from -$0.0 in Q1 2025, and up 27.57% year-over-year from -$0.0 in Q2 2024.
VYNE Therapeutics (VYNE) EPS (Basic) (2017 - 2025) Analysis & Trends
VYNE Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.0 for Q2 2025.
- Quarterly EPS (Basic) rose 27.57% year-over-year to -$0.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$0.0 (up 40.87% YoY) and the FY2025 annual result came in at $0.01, up 1033.12% from the prior year.
- EPS (Basic) was -$0.0 for Q2 2025 at VYNE Therapeutics, roughly flat from -$0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.34 in Q1 2022 and bottomed at -$3.56 in Q1 2021.
- A 5-year average of -$0.41 and a median of -$0.01 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 221.89% — and 2023, when it plunged 146.61%.
- VYNE Therapeutics' EPS (Basic) stood at -$1.12 in 2021, then soared by 38.7% to -$0.69 in 2022, then surged by 99.49% to -$0.0 in 2023, then jumped by 94.64% to -$0.0 in 2024, then gained by 0.4% to -$0.0 in 2025.
- Business Quant data shows VYNE's EPS (Basic) at -$0.0 in Q2 2025, -$0.0 in Q1 2025, and -$0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.69 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | 4.34 |
| Dec 31, 2021 | -1.12 |
| Sep 30, 2021 | -2.42 |
| Jun 30, 2021 | -3.23 |
| Mar 31, 2021 | -3.56 |
| Dec 31, 2020 | -12.87 |
| Sep 30, 2020 | -10.61 |
| Jun 30, 2020 | -86.94 |